- Home
- IMVT vs HTGC Comparison
IMVT vs HTGC Comparison
Compare IMVT & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- HTGC
- Stock Information
- Founded
- IMVT N/A
- HTGC 2003
- Country
- IMVT United States
- HTGC United States
- Employees
- IMVT N/A
- HTGC N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- HTGC Investment Managers
- Sector
- IMVT Health Care
- HTGC Finance
- Exchange
- IMVT Nasdaq
- HTGC Nasdaq
- Market Cap
- IMVT 3.4B
- HTGC 2.8B
- IPO Year
- IMVT N/A
- HTGC 2005
- Fundamental
- Price
- IMVT $15.15
- HTGC $17.54
- Analyst Decision
- IMVT Strong Buy
- HTGC Buy
- Analyst Count
- IMVT 10
- HTGC 8
- Target Price
- IMVT $43.57
- HTGC $21.06
- AVG Volume (30 Days)
- IMVT 2.3M
- HTGC 1.4M
- Earning Date
- IMVT 05-28-2025
- HTGC 05-01-2025
- Dividend Yield
- IMVT N/A
- HTGC 10.91%
- EPS Growth
- IMVT N/A
- HTGC N/A
- EPS
- IMVT N/A
- HTGC 1.61
- Revenue
- IMVT N/A
- HTGC $493,591,000.00
- Revenue This Year
- IMVT $108.88
- HTGC $7.95
- Revenue Next Year
- IMVT N/A
- HTGC $8.96
- P/E Ratio
- IMVT N/A
- HTGC $10.89
- Revenue Growth
- IMVT N/A
- HTGC 7.15
- 52 Week Low
- IMVT $12.72
- HTGC $15.65
- 52 Week High
- IMVT $34.47
- HTGC $22.04
- Technical
- Relative Strength Index (RSI)
- IMVT 40.98
- HTGC 43.38
- Support Level
- IMVT $14.50
- HTGC $17.18
- Resistance Level
- IMVT $15.78
- HTGC $17.66
- Average True Range (ATR)
- IMVT 1.37
- HTGC 0.77
- MACD
- IMVT 0.08
- HTGC 0.01
- Stochastic Oscillator
- IMVT 47.74
- HTGC 50.81
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.